G.R. No. 142738; December 14, 2001
DR. HONORATA BAYLON, petitioner, vs. OFFICE OF THE OMBUDSMAN AND SANDIGANBAYAN, respondents.

FACTS

Petitioner Dr. Honorata Baylon, as Program Manager of the National Voluntary Blood Donation Program under the National Kidney and Transplant Institute (NKTI), was involved in the 1994 procurement of Terumo blood bags from FVA-Exim Trading without public bidding. This purchase was made urgently following a public health crisis: a USAID study revealed safety issues in commercial blood banks, leading the Health Secretary to order their closure and creating an acute blood shortage. The NKTI expedited the purchase to implement a voluntary donation system as an immediate alternative. In 1995, the Commission on Audit (COA) disallowed the transaction in post-audit, alleging overpricing by comparing NKTI’s prices with those given to other institutions like the Philippine National Red Cross, and claimed a government loss of nearly P1.96 million. Based on this, a criminal complaint for violation of the Anti-Graft and Corrupt Practices Act was filed against Dr. Baylon and other officials before the Ombudsman.
The Ombudsman’s Evaluation and Preliminary Investigation Bureau initially recommended dismissal for insufficiency of evidence, finding the purchase justified as an emergency procurement and noting that price comparisons were invalid due to differing payment terms and delivery conditions. However, the Ombudsman disapproved this recommendation and approved a memorandum favoring prosecution. The case was filed with the Sandiganbayan. Dr. Baylon filed this petition, arguing the Ombudsman committed grave abuse of discretion in finding probable cause.

ISSUE

Whether the Office of the Ombudsman committed grave abuse of discretion in finding probable cause to prosecute Dr. Baylon for violation of the Anti-Graft and Corrupt Practices Act.

RULING

Yes, the Supreme Court granted the petition, finding grave abuse of discretion. The Court ruled that the Ombudsman acted arbitrarily, as its finding of probable cause was not supported by substantial evidence and ignored clear facts justifying the purchase. The legal logic is that probable cause requires a reasonable belief that a crime has been committed and the accused is guilty, based on evidence. Here, the purchase was an emergency response to a public health crisis, exempting it from mandatory public bidding under applicable laws. The price disparity cited by COA was misleading, as the compared prices offered to other institutions involved different payment terms (cash) and delivery conditions, unlike NKTI’s contract which involved credit and nationwide delivery. The DOH Investigation Committee and the COA Commission Proper itself later found no overpricing. The Ombudsman’s reliance on the initial COA audit opinion, despite subsequent exonerating facts and the clear exigency of the situation, was capricious. The Court emphasized that the purpose of preliminary investigation is to protect the innocent from hasty prosecution, and agencies must dismiss cases when evidence is patently insufficient. The Ombudsman’s decision to prosecute despite the absence of evidence of bad faith, overpricing, or injury to the government constituted grave abuse of discretion warranting judicial correction.